Full Text
EE522 Cost-Effectiveness Analysis of Abrocitinib Versus Dupilumab in Adolescents With Severe Atopic Dermatitis in Spain

Abstract

Authors

A De Lossada Juste P Fortes A Bellmunt N. Vidal-Vilar

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×